Copyright Reports & Markets. All rights reserved.

Global Drug-Device Combination Products Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Drug-Device Combination Products by Type
    • 1.3.1 Overview: Global Drug-Device Combination Products Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Drug-Device Combination Products Consumption Value Market Share by Type in 2023
    • 1.3.3 Drug-Coated Device
    • 1.3.4 Prefilled Drug Delivery Systems
    • 1.3.5 Nebulizer and Inhaler
    • 1.3.6 Transdermal Delivery System
    • 1.3.7 Others
  • 1.4 Global Drug-Device Combination Products Market by Application
    • 1.4.1 Overview: Global Drug-Device Combination Products Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital andClinic
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Other
  • 1.5 Global Drug-Device Combination Products Market Size & Forecast
  • 1.6 Global Drug-Device Combination Products Market Size and Forecast by Region
    • 1.6.1 Global Drug-Device Combination Products Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Drug-Device Combination Products Market Size by Region, (2019-2030)
    • 1.6.3 North America Drug-Device Combination Products Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Drug-Device Combination Products Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Drug-Device Combination Products Market Size and Prospect (2019-2030)
    • 1.6.6 South America Drug-Device Combination Products Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Drug-Device Combination Products Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 GSK
    • 2.1.1 GSK Details
    • 2.1.2 GSK Major Business
    • 2.1.3 GSK Drug-Device Combination Products Product and Solutions
    • 2.1.4 GSK Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 GSK Recent Developments and Future Plans
  • 2.2 Novo Nordisk
    • 2.2.1 Novo Nordisk Details
    • 2.2.2 Novo Nordisk Major Business
    • 2.2.3 Novo Nordisk Drug-Device Combination Products Product and Solutions
    • 2.2.4 Novo Nordisk Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Novo Nordisk Recent Developments and Future Plans
  • 2.3 Eli Lilly
    • 2.3.1 Eli Lilly Details
    • 2.3.2 Eli Lilly Major Business
    • 2.3.3 Eli Lilly Drug-Device Combination Products Product and Solutions
    • 2.3.4 Eli Lilly Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Eli Lilly Recent Developments and Future Plans
  • 2.4 AstraZeneca
    • 2.4.1 AstraZeneca Details
    • 2.4.2 AstraZeneca Major Business
    • 2.4.3 AstraZeneca Drug-Device Combination Products Product and Solutions
    • 2.4.4 AstraZeneca Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 AstraZeneca Recent Developments and Future Plans
  • 2.5 Sanofi
    • 2.5.1 Sanofi Details
    • 2.5.2 Sanofi Major Business
    • 2.5.3 Sanofi Drug-Device Combination Products Product and Solutions
    • 2.5.4 Sanofi Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Sanofi Recent Developments and Future Plans
  • 2.6 Boston Scientific
    • 2.6.1 Boston Scientific Details
    • 2.6.2 Boston Scientific Major Business
    • 2.6.3 Boston Scientific Drug-Device Combination Products Product and Solutions
    • 2.6.4 Boston Scientific Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Boston Scientific Recent Developments and Future Plans
  • 2.7 Abbott
    • 2.7.1 Abbott Details
    • 2.7.2 Abbott Major Business
    • 2.7.3 Abbott Drug-Device Combination Products Product and Solutions
    • 2.7.4 Abbott Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Abbott Recent Developments and Future Plans
  • 2.8 Boehringer Ingelheim
    • 2.8.1 Boehringer Ingelheim Details
    • 2.8.2 Boehringer Ingelheim Major Business
    • 2.8.3 Boehringer Ingelheim Drug-Device Combination Products Product and Solutions
    • 2.8.4 Boehringer Ingelheim Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.9 Medtronic
    • 2.9.1 Medtronic Details
    • 2.9.2 Medtronic Major Business
    • 2.9.3 Medtronic Drug-Device Combination Products Product and Solutions
    • 2.9.4 Medtronic Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Medtronic Recent Developments and Future Plans
  • 2.10 Mylan
    • 2.10.1 Mylan Details
    • 2.10.2 Mylan Major Business
    • 2.10.3 Mylan Drug-Device Combination Products Product and Solutions
    • 2.10.4 Mylan Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Mylan Recent Developments and Future Plans
  • 2.11 3M
    • 2.11.1 3M Details
    • 2.11.2 3M Major Business
    • 2.11.3 3M Drug-Device Combination Products Product and Solutions
    • 2.11.4 3M Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 3M Recent Developments and Future Plans
  • 2.12 Hisamitsu
    • 2.12.1 Hisamitsu Details
    • 2.12.2 Hisamitsu Major Business
    • 2.12.3 Hisamitsu Drug-Device Combination Products Product and Solutions
    • 2.12.4 Hisamitsu Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Hisamitsu Recent Developments and Future Plans
  • 2.13 Smith & Nephew
    • 2.13.1 Smith & Nephew Details
    • 2.13.2 Smith & Nephew Major Business
    • 2.13.3 Smith & Nephew Drug-Device Combination Products Product and Solutions
    • 2.13.4 Smith & Nephew Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Smith & Nephew Recent Developments and Future Plans
  • 2.14 Molnlycke
    • 2.14.1 Molnlycke Details
    • 2.14.2 Molnlycke Major Business
    • 2.14.3 Molnlycke Drug-Device Combination Products Product and Solutions
    • 2.14.4 Molnlycke Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Molnlycke Recent Developments and Future Plans
  • 2.15 Teleflex
    • 2.15.1 Teleflex Details
    • 2.15.2 Teleflex Major Business
    • 2.15.3 Teleflex Drug-Device Combination Products Product and Solutions
    • 2.15.4 Teleflex Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Teleflex Recent Developments and Future Plans
  • 2.16 BD
    • 2.16.1 BD Details
    • 2.16.2 BD Major Business
    • 2.16.3 BD Drug-Device Combination Products Product and Solutions
    • 2.16.4 BD Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 BD Recent Developments and Future Plans
  • 2.17 Lepu Medical
    • 2.17.1 Lepu Medical Details
    • 2.17.2 Lepu Medical Major Business
    • 2.17.3 Lepu Medical Drug-Device Combination Products Product and Solutions
    • 2.17.4 Lepu Medical Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Lepu Medical Recent Developments and Future Plans
  • 2.18 MicroPort
    • 2.18.1 MicroPort Details
    • 2.18.2 MicroPort Major Business
    • 2.18.3 MicroPort Drug-Device Combination Products Product and Solutions
    • 2.18.4 MicroPort Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 MicroPort Recent Developments and Future Plans
  • 2.19 Terumo
    • 2.19.1 Terumo Details
    • 2.19.2 Terumo Major Business
    • 2.19.3 Terumo Drug-Device Combination Products Product and Solutions
    • 2.19.4 Terumo Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.19.5 Terumo Recent Developments and Future Plans
  • 2.20 B. Braun
    • 2.20.1 B. Braun Details
    • 2.20.2 B. Braun Major Business
    • 2.20.3 B. Braun Drug-Device Combination Products Product and Solutions
    • 2.20.4 B. Braun Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.20.5 B. Braun Recent Developments and Future Plans
  • 2.21 Antares Pharma
    • 2.21.1 Antares Pharma Details
    • 2.21.2 Antares Pharma Major Business
    • 2.21.3 Antares Pharma Drug-Device Combination Products Product and Solutions
    • 2.21.4 Antares Pharma Drug-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.21.5 Antares Pharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Drug-Device Combination Products Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Drug-Device Combination Products by Company Revenue
    • 3.2.2 Top 3 Drug-Device Combination Products Players Market Share in 2023
    • 3.2.3 Top 6 Drug-Device Combination Products Players Market Share in 2023
  • 3.3 Drug-Device Combination Products Market: Overall Company Footprint Analysis
    • 3.3.1 Drug-Device Combination Products Market: Region Footprint
    • 3.3.2 Drug-Device Combination Products Market: Company Product Type Footprint
    • 3.3.3 Drug-Device Combination Products Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Drug-Device Combination Products Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Drug-Device Combination Products Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Drug-Device Combination Products Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Drug-Device Combination Products Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Drug-Device Combination Products Consumption Value by Type (2019-2030)
  • 6.2 North America Drug-Device Combination Products Market Size by Application (2019-2030)
  • 6.3 North America Drug-Device Combination Products Market Size by Country
    • 6.3.1 North America Drug-Device Combination Products Consumption Value by Country (2019-2030)
    • 6.3.2 United States Drug-Device Combination Products Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Drug-Device Combination Products Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Drug-Device Combination Products Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Drug-Device Combination Products Consumption Value by Type (2019-2030)
  • 7.2 Europe Drug-Device Combination Products Consumption Value by Application (2019-2030)
  • 7.3 Europe Drug-Device Combination Products Market Size by Country
    • 7.3.1 Europe Drug-Device Combination Products Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Drug-Device Combination Products Market Size and Forecast (2019-2030)
    • 7.3.3 France Drug-Device Combination Products Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Drug-Device Combination Products Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Drug-Device Combination Products Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Drug-Device Combination Products Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Drug-Device Combination Products Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Drug-Device Combination Products Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Drug-Device Combination Products Market Size by Region
    • 8.3.1 Asia-Pacific Drug-Device Combination Products Consumption Value by Region (2019-2030)
    • 8.3.2 China Drug-Device Combination Products Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Drug-Device Combination Products Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Drug-Device Combination Products Market Size and Forecast (2019-2030)
    • 8.3.5 India Drug-Device Combination Products Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Drug-Device Combination Products Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Drug-Device Combination Products Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Drug-Device Combination Products Consumption Value by Type (2019-2030)
  • 9.2 South America Drug-Device Combination Products Consumption Value by Application (2019-2030)
  • 9.3 South America Drug-Device Combination Products Market Size by Country
    • 9.3.1 South America Drug-Device Combination Products Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Drug-Device Combination Products Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Drug-Device Combination Products Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Drug-Device Combination Products Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Drug-Device Combination Products Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Drug-Device Combination Products Market Size by Country
    • 10.3.1 Middle East & Africa Drug-Device Combination Products Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Drug-Device Combination Products Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Drug-Device Combination Products Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Drug-Device Combination Products Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Drug-Device Combination Products Market Drivers
  • 11.2 Drug-Device Combination Products Market Restraints
  • 11.3 Drug-Device Combination Products Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Drug-Device Combination Products Industry Chain
  • 12.2 Drug-Device Combination Products Upstream Analysis
  • 12.3 Drug-Device Combination Products Midstream Analysis
  • 12.4 Drug-Device Combination Products Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.
    According to our (Global Info Research) latest study, the global Drug-Device Combination Products market size was valued at US$ 38440 million in 2023 and is forecast to a readjusted size of USD 57890 million by 2030 with a CAGR of 6.1% during review period.
    Global key drug-device combination products players include GSK, Novo Nordisk and Eli Lilly etc. The top 3 companies hold a share about 32%. North America is the largset market with a share about 42%, followed by Europe and Asia-Pacific.
    In terms of product, nebulizer & inhaler is the largest segment with a share about 36%. And in terms of applications, the largset application is hospital and clinic with a share about 47%.
    This report is a detailed and comprehensive analysis for global Drug-Device Combination Products market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Drug-Device Combination Products market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Drug-Device Combination Products market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Drug-Device Combination Products market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Drug-Device Combination Products market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Drug-Device Combination Products
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Drug-Device Combination Products market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Boehringer Ingelheim, Medtronic, Mylan, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Drug-Device Combination Products market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Drug-Device Combination Products market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Drug-Coated Device
    Prefilled Drug Delivery Systems
    Nebulizer and Inhaler
    Transdermal Delivery System
    Others
    Market segment by Application
    Hospital andClinic
    Retail Pharmacies
    Other
    Market segment by players, this report covers
    GSK
    Novo Nordisk
    Eli Lilly
    AstraZeneca
    Sanofi
    Boston Scientific
    Abbott
    Boehringer Ingelheim
    Medtronic
    Mylan
    3M
    Hisamitsu
    Smith & Nephew
    Molnlycke
    Teleflex
    BD
    Lepu Medical
    MicroPort
    Terumo
    B. Braun
    Antares Pharma
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Drug-Device Combination Products product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Drug-Device Combination Products, with revenue, gross margin, and global market share of Drug-Device Combination Products from 2019 to 2024.
    Chapter 3, the Drug-Device Combination Products competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Drug-Device Combination Products market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Drug-Device Combination Products.
    Chapter 13, to describe Drug-Device Combination Products research findings and conclusion.

    Buy now